TP53 Gain-of-Function and Non–Gain-of-Function Mutations Are Differentially Associated With Sidedness-Dependent Prognosis in Metastatic Colorectal Cancer We evaluated the efficacy and safety of ...

Vunakizumab significantly improved clinical responses in active psoriatic arthritis in a phase 2 trial. Read more about the study.

Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients With Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU) DRD biomarker–positive mUC ...

HOUSTON--(BUSINESS WIRE)--Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) ...

In a new phase 3, double-blind study, researchers explored the efficacy and safety of combination therapy using subcutaneous (SC) belimumab and rituximab for the treatment of active systemic lupus ...

Research indicates that many statin therapy side effects are not supported by evidence, suggesting a need for revised ...

Medically reviewed by Kate Colby, MPH Key Takeaways In a double-blind trial, neither the patient nor the researcher knows who gets the treatment.A placebo-controlled trial uses a fake drug to test ...

Objectives To investigate if daily treatment with glyceryl trinitrate (GTN) ointment, over 24 weeks combined with a 12-week eccentric exercise programme is more effective for chronic mid-portion ...

“Can the blind lead the blind? Shall they not both fall into the pit?” Luke 6:39 While “the blind leading the blind” has become an often-used idiom of incompetency and ineffectiveness, the “randomized ...